Corporate Governance Report not applicable for Q2 FY 2026

Compliance View source PDF Explain this filing

SHEEL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.1%Reaction day

₹60.80

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.8% vs market

On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-2.1+0.7-2.8

Next day

+2.8-1.0+3.7

—-0.3—

—-1.9—

-1.2-4.5+3.2

-1.2-5.5+4.2

—-7.3—

15d

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sheel Biotech Limited told the NSE that filing a Corporate Governance Report for the quarter ended 30 September 2026 is not required. Since the company is listed on the NSE SME platform, it is exempt under Regulation 15(2) of SEBI LODR Rules. The company said it will follow the rules if they become applicable to it at a later stage.

Likely market impact

Routine compliance filing with no material impact on shareholders or stock price; standard exemption notice for an SME-listed firm.